Taizhou, China

Zhaozhao Zhang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhaozhao Zhang: Innovator in Pharmaceutical Crystallization

Introduction

Zhaozhao Zhang is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystal forms of medications. His work focuses on enhancing the properties of pharmaceutical compounds to improve their efficacy and stability.

Latest Patents

Zhaozhao Zhang holds a patent for the "Crystal form of dabigatran etexilate mesylate and preparation method and use thereof." This invention relates to novel crystal forms M and N of dabigatran etexilate mesylate. The X-Ray powder diffractogram of crystal form M exhibits characteristic peaks at specific 2θ diffraction angles, while crystal form N has its own distinct set of peaks. These crystal forms demonstrate excellent properties in terms of leaching time, biological release, chemical stability, and processing adaptability. He has 1 patent to his name.

Career Highlights

Zhaozhao Zhang is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical research and development. His innovative approaches have contributed to advancements in drug formulation and delivery systems.

Collaborations

Zhaozhao Zhang has worked alongside talented colleagues such as Liang Zhang and Chuan Liu. Their collaborative efforts have furthered research in the field of pharmaceutical sciences.

Conclusion

Zhaozhao Zhang's contributions to the pharmaceutical industry through his innovative patent work exemplify the importance of research and development in improving drug formulations. His achievements highlight the potential for advancements in medication efficacy and stability.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…